Ferran Nadeu

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications

Genomic Architecture of IRF4 Rearrangements in Children and Adult Large B-cell Lymphomas.

Genomic Architecture of IRF4 Rearrangements in Children and Adult Large B-cell Lymphomas.

Journal: Blood advances
Published: March 20, 2026

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

Journal: Blood
Published: December 05, 2025

The biology and evolution of Richter transformation in chronic lymphocytic leukemia.

The biology and evolution of Richter transformation in chronic lymphocytic leukemia.

Journal: Seminars in cancer biology
Published: November 02, 2025

Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups.

Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups.

Journal: HemaSphere
Published: October 10, 2025

Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.

Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.

Journal: Leukemia
Published: July 04, 2025

The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma.

The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma.

Journal: Scientific reports
Published: June 12, 2025

Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia.

Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia.

Journal: Blood
Published: May 28, 2025

C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia.

C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia.

Journal: Scientific reports
Published: May 06, 2025

Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.

Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.

Journal: Frontiers in immunology
Published: April 01, 2025

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Journal: Leukemia
Published: January 03, 2025

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Journal: Leukemia
Published: December 20, 2024

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.

Journal: Cells
Published: September 20, 2024
Showing 1-12 of 101

Last Updated: 09/26/2026